Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19?

Journal of cellular and molecular medicine - 1 Nov 2020

Sarantis Panagiotis, Koustas Evangelos, Papavassiliou Athanasios G, Karamouzis Michalis V

Abstract excerpt

Undoubtedly, the new SARS-CoV-2 virus poses a grave health threat, plaguing the health and socio-economic sectors. COVID-19 disease must be treated quickly and effectively as soon as possible. The main axes in this direction are establishing vaccines, drugs, diagnostic tests, as well as identifying the most vulnerable groups. Probably, there is a correlation between COVID-19 and cystic fibrosis. Our interest is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Genetic Predisposition to Disease

Share to Inflammation

Share to Mutation

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33009727
DOI: 10.1111/jcmm.15941
PMCID: PMC7675715

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19?PMID 33009727Read ↗

Does Cystic Fibrosis Constitute an Advantage in COVID-19 Infection?Semantic proximity Read ↗

COVID-19 meets Cystic Fibrosis: for better or worse?Semantic proximity Read ↗

Anti-Fibrotic Agents Could Be the Game Changer for Post‑COVID Pulmonary Fibrosis Treatment – A Mini ReviewSemantic proximity Read ↗

COVID-19 Susceptibility in chronic obstructive pulmonary disease.Semantic proximity Read ↗

TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 PathogenesisSemantic proximity Read ↗

Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.Semantic proximity Read ↗

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.Semantic proximity Read ↗

Is Covid-19 Severity Associated With ACE2 Degradation?Semantic proximity Read ↗

Skin biomarkers for cystic fibrosis: a potential noninvasive approach for patient screeningSemantic proximity Read ↗

[Characteristics and specificities of cystic fibrosis in adults: evolutive disease of childhood or recently diagnosed disease?].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.